antiarrhythmic therapy

antiarrhythmic therapy

Cardiology The use of therapeutic agents to counteract potentially life-threatening and refractory ventricular arrhythmias, and ↓ mortality; the Vaughn Williams/Harrison classification divides antiarrhythmic agents into 5 groups. Cf Proarrhythmic effect.
References in periodicals archive ?
Patients with diabetes mellitus, cerebrovascular accident, heart failure, bundle branch block, systemic arterial hypertension and ongoing antiarrhythmic therapy were excluded from the study.
Other patients were divided into three groups: patients with some kind of antiarrhythmic therapy before and continued after the surgery; patients with diltiazem prophylaxis; and patients without any antiarrhythmic prophylaxis.
Oral antiarrhythmic therapy may be required, because attempts to wean patients from isoproterenol can result in recurrent VF.
Findings could lead to new efforts to better man-age AF by gender, including antiarrhythmic therapy and radiofrequency ablation, researchers write.
Indeed, the future of antiarrhythmic therapy lies in neuromodulation of the autonomic nervous system, and it's a lot closer than most cardiologists realize, according to the electrophysiologist.
Lignocaine should not be used as antiarrhythmic therapy.
Thus, it will definitely expand our understanding of antiarrhythmic therapy from the pharmacological stand point of view.
A total of 2202 patients with established coronary artery atherosclerotic disease, LVEF of 40% or less, and asymptomatic NSVT, were assigned to either no therapy or electrophysiologic study (EPS)-guided antiarrhythmic therapy with drugs and/or ICD.
6% of RealiseAF patients on amiodarone as firstline antiarrhythmic therapy, one-half did not qualify according to the 2006 joint American College of Cardiology/American Heart Association/European Society of Cardiology AF guidelines.
Chronic antiarrhythmic therapy is not necessary, however; atrial flutter associated with postoperative procedure may be resistance to electrical cardioversion or persistent, requiring the use of antiarrhythmic medications (1, 5).
Choosing the right drug Without chronic antiarrhythmic therapy, only about 30% of patients with AF will remain in normal sinus rhythm after a year.
Implantable cardioverter defibrillator (ICD) has been shown to decrease the incidence of SCD in primary prevention in patients with LV systolic dysfunction, as well as in secondary prevention when compared to antiarrhythmic therapy.